Condition
Allogenic Stem Cell Transplantation
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Withdrawn1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07758218Phase 1Not Yet RecruitingPrimary
Allogeneic iNKT Cell Therapy (agenT-797) After SCT
NCT05726682Phase 2WithdrawnPrimary
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Showing all 2 trials